Source: Financial Modeling Prep · peers by sector/industry
2024-02-15
$0.6537
2024-04-05
2023-11-24
$0.6576
2024-01-08
Stock splits
Execution date
Ratio
2016-07-22
2-for-1
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Valuation
Trading at 6.6× earnings vs its 9.2× historical median P/E.
Fair value ≈ $51.96 · price $37.16 today
Undervalued · 28% below
Loading valuation…
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
$IMBBY Anyone else betting on Cuba's collapse and therefore the removal of embargo. Imagine allowing the US market to import premium cuban cigars. We're talking way over 1b business short term
$CHUC The sell off doesn’t make sense, especially with sales increasing so much. And then we have this article where $BTI suspends their Suspends U.S. Vape Rollout Following Regulatory Pressure
https://finance.yahoo.com/news/british-american-tobacco-bti-suspends-015522056.html
Wouldn’t it make sense for them to partner with CHUC to sell SBX legally? Hell, this applies to any Big Tobacco company. With the age-gate technology, it could be a game changer for the vape industry. $MO $IMBBY $VGR
$CBWTF straight from $IMBBY via SEDAR, how the latest debt reduction looks:
https://www.sedarplus.ca/csa-party/records/document.html?id=593deebe896d45cdf877c91361df1469b2b33b0db422bb5e6672ef9436e54b80
I found you an Overbought RSI (Relative Strength Index) on the daily chart of Imperial Brands PLC. Is that bullish or bearish? $IMBBY #RsiOverbought #OTCQX
Sharing some thoughts on Imperial Brands PLC and the value of the stock. Would love to hear what people think about the future. Do all tobacco companies transition and survive with alternative offerings? $IMBBY
https://fatalpha.substack.com/p/accounting-for-the-decline-in-smoking
$MO $BTI $IMBBY $PM
U.S. tariffs should be 'manageable' for global tobacco companies, says UBS
President Trump's new tariffs on U.S. imports, including a 10% baseline tariff on imports from all countries, should be "manageable" for global tobacco companies, UBS tells investors in a research note. At the same time, the firm says the broader impact from the tariffs could be negative for the U.S. consumer, which could continue to negatively impact U.S. cigarette volumes, though economic uncertainty is likely to continue to benefit the defensiveness and low volatility of the tobacco sector, resulting in the continued outperformance of the tobacco sector. Publicly traded companies under the firm's coverage include Altria (MO), BAT (BTI), Imperial Brands (IMBBY), and Philip Morris (PM).
$IMBBY earnings around the corner! 📈 Fresh numbers will reveal how the entertainment giant's navigating this wild market. Analysts eyeing streaming growth & theme park revivals. Keep those notifications on—this could spark some moves. Let’s see how they play their cards this quarter.
